Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

(03) 9028 2888

clients@freshequities.com

ASX:BGT logo

ASX:BGT

Bio-Gene Technology Ltd

$0.145

0.00 (0.00%)

Last trade: Invalid date GMT

-

Investor Presentations

Principal Activity

Bio-Gene Technology Ltd (BGT) is an Australian public biotechnology company that is developing a patent protected product platform as a new class of insecticides. Bio-Gene owns patents covering the use of these -triketone insecticides for insect control. Bio-Gene's is developing two products targeted at different sectors of the insecticide market. The natural product Qcide - is an oil extracted from the leaves of a rare cultivar of an Australian eucalypt, the Gympie Messmate (Eucalyptus cloeziana). This product is focused on organic insect control. FLAVOCIDE - is a chemically synthesised product developed as a nature identical molecule to molecules also found in Eucalyptus cloeziana extracts.

News

Announcements

Filter

All categories
Investor Presentations
Trading Halt
Qtly Cashflow
Issued Capital
Periodic Reports
AnnouncementT+2 MovementDate

Market Data

Day

3m

1yr

5yr

Current price

-

Open price

-

Day low-high

-

Price change

-

Percent change

-

Previous close

-

Volume

-

Turnover

-

Bid price

-

Ask price

-

Market cap

-

Shares outstanding

-

Year high

-

Year low

-

Year low-high

-

Earnings per share

-

Price/earnings ratio

-

Dividend yield

-

Dividend per share

-

Franking

-

Investor Presentations

News

Raise History

Sector Peers

RankCompanyMarket Cap
Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 19, 15 William St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.